Taurine chloramine inhibits production of inflammatory mediators and iNOS gene expression in alveolar macrophages; a tale of two pathways: part I, NF-kappaB signaling.
Quinn
Michael R
MR
Center for Developmental Neuroscience, Staten Island, NY, USA.
Barua
Madhabi
M
Liu
Yong
Y
Serban
Valeria
V
D000818:Animals; D002460:Cell Line; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D018836:Inflammation Mediators / Q000378:metabolism*; D016676:Macrophages, Alveolar / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052247:Nitric Oxide Synthase Type II; D011401:Promoter Regions, Genetic; D051381:Rats; D015398:Signal Transduction; D013654:Taurine / Q000031:analogs & derivatives* / Q000494:pharmacology*
D018836:Inflammation Mediators; D016328:NF-kappa B; D013654:Taurine; C043410:N-chlorotaurine; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat